Brenton R. Graveley, Ph.D.

Professor and Chair, Genetics and Genome Sciences University of Connecticut

  • Farmington CT

Professor Graveley is an expert in genetics and genomic sciences, with particular focus on RNA biology.

Contact

University of Connecticut

View more experts managed by University of Connecticut

Biography

Brenton Graveley is a professor and chair of Genetics and Genome Sciences at UConn Health and is associate director of the UConn Institute for Systems Genomics. He is the Health Net, Inc. Endowed Chair in Genetics and Developmental Biology and the director of the UConn Stem Cell Institute.

Brent has studied RNA biology throughout his entire career. He performed his undergraduate studies at the University of Colorado, Boulder with David Prescott, his graduate studies at the University of Vermont with Greg Gilmartin, and his postdoctoral studies at Harvard University with Tom Maniatis. Brent has led large components of the ENCODE and modENCODE projects, studies the mechanisms of alternative splicing using genomic, genetic, and biochemical approaches, and collaborates extensively to investigate various aspects of RNA biology.

Areas of Expertise

Micro RNAs
Genetics and Genomics
Genome Sciences
RNA Biology

Education

University of Vermont

Ph.D.

Microbiology and Molecular Genetics

University of Colorado

B.A.

Molecular, Cellular, and Developmental Biology

Accomplishments

Elected Member, Connecticut Academy of Science and Engineering

Lifetime

Social

Media Appearances

The future of genetics: UConn professor building ‘encyclopedia’ of human genes

Hearst Connecticut Media  print

2020-08-30

A team at UConn is part of an international consortium of scientists taking the next step toward the end of congenital disease.

The entirety of the human genetic sequence has been mapped for some time. The Human Genome Project finished its work in 1993, but as Brenton Graveley explained, that was only the beginning.

It was like having a dictionary, he said, without knowing how to build a sentence.

View More

New insights into human and mouse genomes published in NIH study

Drug Target Review  online

2020-07-30

“The data generated in ENCODE 3 dramatically increase our understanding of the human genome,” said Professor Brenton Graveley, chair of the Department of Genetics and Genome Sciences at UCONN Health. “The project has added tremendous resolution and clarity for previous data types, such as DNA-binding proteins and chromatin marks and new data types, such as long-range DNA interactions and protein-RNA interactions.”

View More

A better way to read the genome

Phys.org  online

2015-10-09

Genomicists Brenton Graveley from the UConn Institute of Systems Genomics, postdoctoral fellow Mohan Bolisetty, and graduate student Gopinath Rajadinakaran teamed up with UK-based Oxford Nanopore Technologies to show that the company's MinION nanopore sequencer can sequence genes faster, better, and at a much lower cost than the standard technology. They published their findings on Sept. 30 in Genome Biology.

View More

Articles

Histones direct site-specific CRISPR spacer acquisition in model archaeon

Nature Microbiology

2023

CRISPR–Cas systems provide heritable immunity against viruses and other mobile genetic elements by incorporating fragments of invader DNA into the host CRISPR array as spacers. Integration of new spacers is localized to the 5′ end of the array, and in certain Gram-negative Bacteria this polarized localization is accomplished by the integration host factor. For most other Bacteria and Archaea, the mechanism for 5′ end localization is unknown. Here we show that archaeal histones play a key role in directing integration of CRISPR spacers. In Pyrococcus furiosus, deletion of either histone A or B impairs integration.

View more

Investigation of CRISPR-Independent Phage Resistance Mechanisms Reveals a Role for FtsH in Phage Adsorption to Streptococcus thermophilus

Journal of Bacteriology

2023

Prokaryotes are under constant pressure from phage infection and thus have evolved multiple means of defense or evasion. While CRISPR-Cas constitutes a robust immune system and appears to be the predominant means of survival for Streptococcus thermophilus when facing lytic phage infection, other forms of phage resistance coexist in this species. Here, we show that S. thermophilus strains with deleted CRISPR-Cas loci can still give rise to phage-resistant clones following lytic phage challenge. Notably, non-CRISPR phage-resistant survivors had multiple mutations which would truncate or recode a membrane-anchored host protease, FtsH.

View more

RBP Image Database: A resource for the systematic characterization of the subcellular distribution properties of human RNA binding proteins

Nucleic Acids Research

2023

RNA binding proteins (RBPs) are central regulators of gene expression implicated in all facets of RNA metabolism. As such, they play key roles in cellular physiology and disease etiology. Since different steps of post-transcriptional gene expression tend to occur in specific regions of the cell, including nuclear or cytoplasmic locations, defining the subcellular distribution properties of RBPs is an important step in assessing their potential functions. Here, we present the RBP Image Database, a resource that details the subcellular localization features of 301 RBPs in the human HepG2 and HeLa cell lines, based on the results of systematic immuno-fluorescence studies conducted using a highly validated collection of RBP antibodies and a panel of 12 markers for specific organelles and subcellular structures.

View more

Show All +